Strano S - Search Results

1

EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors.

Avraham R, Sas-Chen A, Manor O, Steinfeld I, Shalgi R, Tarcic G, Bossel N, Zeisel A, Amit I, Zwang Y, Enerly E, Russnes HG, Biagioni F, Mottolese M, Strano S, Blandino G, Børresen-Dale AL, Pilpel Y, Yakhini Z, Segal E, Yarden Y. Avraham R, et al. Among authors: strano s. Sci Signal. 2010 Jun 1;3(124):ra43. doi: 10.1126/scisignal.2000876. Sci Signal. 2010. PMID: 20516477

2

BCL-2: the pendulum of the cell fate.

Blandino G, Strano S. Blandino G, et al. Among authors: strano s. J Exp Clin Cancer Res. 1997 Mar;16(1):3-10. J Exp Clin Cancer Res. 1997. PMID: 9148853

3

Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network.

Tzahar E, Moyer JD, Waterman H, Barbacci EG, Bao J, Levkowitz G, Shelly M, Strano S, Pinkas-Kramarski R, Pierce JH, Andrews GC, Yarden Y. Tzahar E, et al. Among authors: strano s. EMBO J. 1998 Oct 15;17(20):5948-63. doi: 10.1093/emboj/17.20.5948. EMBO J. 1998. PMID: 9774339 Free PMC article.

4

The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.

Waterman H, Alroy I, Strano S, Seger R, Yarden Y. Waterman H, et al. Among authors: strano s. EMBO J. 1999 Jun 15;18(12):3348-58. doi: 10.1093/emboj/18.12.3348. EMBO J. 1999. PMID: 10369675 Free PMC article.

5

p73-mediated chemosensitivity: a preferential target of oncogenic mutant p53.

Strano S, Blandino G. Strano S, et al. Cell Cycle. 2003 Jul-Aug;2(4):348-9. Cell Cycle. 2003. PMID: 12851488 Review. No abstract available.

6

Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells.

Weisz L, Damalas A, Liontos M, Karakaidos P, Fontemaggi G, Maor-Aloni R, Kalis M, Levrero M, Strano S, Gorgoulis VG, Rotter V, Blandino G, Oren M. Weisz L, et al. Among authors: strano s. Cancer Res. 2007 Mar 15;67(6):2396-401. doi: 10.1158/0008-5472.CAN-06-2425. Cancer Res. 2007. PMID: 17363555

7

Mutant p53: an oncogenic transcription factor.

Strano S, Dell'Orso S, Di Agostino S, Fontemaggi G, Sacchi A, Blandino G. Strano S, et al. Oncogene. 2007 Apr 2;26(15):2212-9. doi: 10.1038/sj.onc.1210296. Oncogene. 2007. PMID: 17401430 Review.

8

YAP1 meets tumor suppression.

Strano S, Blandino G. Strano S, et al. Mol Cell. 2007 Sep 21;27(6):863-4. doi: 10.1016/j.molcel.2007.09.004. Mol Cell. 2007. PMID: 17889659 Free article.

9

Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy.

Bossi G, Marampon F, Maor-Aloni R, Zani B, Rotter V, Oren M, Strano S, Blandino G, Sacchi A. Bossi G, et al. Among authors: strano s. Cell Cycle. 2008 Jun 15;7(12):1870-9. doi: 10.4161/cc.7.12.6161. Epub 2008 Jun 16. Cell Cycle. 2008. PMID: 18594199

10

Tetraploidy triggers mitochondria.

Benassi B, Strano S, Blandino G. Benassi B, et al. Among authors: strano s. Cell Cycle. 2009 May 1;8(9):1305-6. doi: 10.4161/cc.8.9.8685. Cell Cycle. 2009. PMID: 19377300 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page